YHEC is a market leader in the development of a wide range of economic evaluations including:
We have a proven track record of developing cost-effectiveness models from a global perspective that are robust enough to support submission to advanced health technology assessment (HTA) agencies such as the National Institute for Health and Care Excellence (NICE), Scottish Medicines Consortium (SMC), All Wales Medicines Strategy Group (AWMSG), Canadian Agency for Drugs and Technologies in Health (CADTH) and Institute for Clinical and Economic Review (ICER). We also regularly develop more simple models to support local reimbursement / negotiations or internal pricing decision making.
The health economic modelling team also provides the following services:
- Model critique and validation
- Model adaptation
- Manuscript preparation
- Bespoke training
Our client base covers the pharmaceutical and medical device industries (large and small) as well as national organisations such NICE, Public Health England and NHS England. Services can be tailored to meet the specific needs of each of these clients.
Please click on the headings below for further information.